development of divergent syntheses of NAD(P) analogues,
it came to our attention that very few ADP-ribose derivatives
possessing modified pyrophosphate linkages had been re-
ported in the literature.10 In addition, Blackburn reported the
only pyrophosphonate derivatives of ADP and ATP, in which
the oxygen of a P-O-P bond had been replaced by an
alkynyl moiety.11-13 In the ATP analogue, the substitution
took place between the â- and the γ-phosphorus atoms and
the synthesis involved the condensation of AMP-morpholi-
date with acetylene-1,2-bisphosphonic acid obtained from
the Michaelis-Arbusov reaction between dichloroethyne and
triethyl phosphite. Such alkynyl-containing bisphosphonates
were shown to have lower pKas than the corresponding
pyrophosphates due to the lack of hydrogen bond between
the Pâ-O-H and the Pγ-O- caused by the linear acetylenic
linkage.11 It can be anticipated that at physiological pH, an
acetylenic-containing pyrophosphonate ADP-ribose analogue
could have equal capabilities for ionic interactions with
enzyme binding residues as its parent pyrophosphate. How-
ever, weaker complexes are to be expected between this type
of pyrophosphonate and Mg2+ present in the pyrophosphatase
binding pocket. This assumption is based on Blackburn’s
work with alkynyl-containing ATP analogues and Ca2+.11
Yet, long-range interactions between acetylene bisphospho-
nate-containing nucleotides and binding residues and metals
through enzyme bond-water molecules can also be antici-
pated.14,15
As a consequence, we decided to synthesize the ADP-
ribose analogue (2, Figure 1) in which the bridging oxygen
has been exchanged for an alkynyl moiety. This analogue
can be viewed as a mimic of the transition state occurring
during the enzymatic cleavage of the P-O-P bond as the
distance between the two phosphorus atoms has been
calculated to differ by 2 Å (calculated P-P distance; 2.8 Å
in P-O-P and 4.8 Å in P-CC-P).16 In addition to the
binding interactions anticipated to occur between enzyme
and analogue, it is hoped that the acetylenic pyrophosphonate
will participate in some new enzymatic chemistry. Indeed,
in the presence of a strong nucleophile, tetraethyl 1,2-ethynyl
bisphosphonate was shown to decompose via the rupture of
one of the P-C bonds.17 Such chemical behavior could lead
Scheme 1. Synthesis of R/â 1,2,3-Tri-O,O,O-acetyl
D-Ribose 5a
a Conditions: (a) CH3OH, H-Dowex resin, rt, 48 h. (b)
(CH3O)2C(CH3)2, H-Dowex resin, rt, 12 h. (c) CH3CH2CH2Br, BaO,
wet DMF, rt, 12 h, 92%. (d) CH3COOH glacial, (CH3CO)2O, H2SO4
cat., 0 °C, 12 h. (e) PdCl2, DCM/CH3OH (1/1), 0 °C to room
temperature, 4 h, 75%.
to an unprecedented mode of irreversible inhibition of
pyrophosphatases. Similarly, in the presence of an acidic
residue, addition of an enzyme nucleophilic residue across
the triple bond can be anticipated,17 once again, leading to
covalent bonding and irreversible inhibition. To the authors’
knowledge, no analogue for which an alkynyl moiety has
been introduced between the R- and â-phosphorus atoms of
a sugar nucleoside diphosphate has been synthesized. Here,
we report a versatile synthesis of the bisphosphonate
acetylene analogue of ADP-ribose (2, Figure 1).
The synthesis of the ADP-ribose analogue 2 was achieved
via the early introduction of an alkynyl-phosphonate moiety
(Scheme 1). Allyloxy diisopropylaminotrimethylsilylethynyl-
phosphine (3, Scheme 2) was prepared from trichlorophos-
phine and allyl alcohol in the presence of pyridine to yield
allyloxy dichlorophosphine (31P NMR 178.3 ppm), which
was then converted to the allyloxy chlorodiisopropylamino-
phosphine (31P NMR 182.0 ppm).18 Subsequent treatment
with trimethylsilyl acetylene in the presence of n-BuLi in
THF at -78 °C gave 3. The use of an allyl-protecting group
was essential for completing the synthesis of 2, as other
alkoxy groups were initially employed unsuccessfully. While
the methyl-protected diisopropylaminotrimethylsilylethynyl-
phosphine was a suitable reagent for the synthesis of the
Scheme 2. Synthesis of Intermediate 7a
(5) Gabelli, S. B.; Bianchet, M. A.; Ohnishi, Y.; Ichikawa, Y.; Bessman,
M. J.; Amzel, L. M. Biochemistry 2002, 41, 9279.
(6) Kang, L. W.; Gabelli, S. B.; Cunningham, J. E.; O’Handley, S. F.;
Amzel, L. M. Structure 2003, 11, 1015.
(7) Shen, B. W.; Perraud, A. L.; Scharenberg, A.; Stoddard, B. L. J.
Mol. Biol. 2003, 332, 385.
(8) Bellamacina, C. R. FASEB J. 1996, 10, 1257.
(9) Bottoms, C. A.; Smith, P. E.; Tanner, J. J. Protein Sci. 2002, 11,
2125.
(10) Pankiewicz, K. W.; Lesiak, K.; Watanabe, K. A. J. Am. Chem. Soc.
1997, 119, 3691.
(11) Blackburn, G. M.; Kent, D. E.; Kolkmann, F. J. Chem. Soc., Perkin
Trans. 1 1984, 1119.
(12) Spelta, V.; Mekhalfia, A.; Rejman, D.; Thompson, M.; Blackburn,
G. M.; North, R. A. Brit. J. Pharm. 2003, 140, 1027.
(13) Blackburn, G. M.; Forster, A. R.; Guo, M.-J.; Taylor, G. E. J. Chem.
Soc., Perkin Trans. 1 1991, 2867.
(14) Gabelli, S. B.; Bianchet, M. A.; Bessman, M. J.; Amzel, L. M.
Nature Struct. Biol. 2001, 8, 467.
(15) Clarke, P.; Lincoln, S. F.; Tiekink, E. R. T. Inorg. Chem. 1991, 30,
2747.
(16) Migaud, M. E.; Malone, J. F. Unpublished results of calculations
on Gaussian Package.
a Conditions: (f) 5, 2,4-DNP, CH3CN, rt, 2 h. (g) H2O2, DCM,
0 °C, 7 min. (h) 50% CsF, CH3CH2OH, rt, 1 h. (i) Allyloxychlo-
rodiisopropylaminophosphine, n-BuLi, THF, -78 °C, 1 h, 53%.
3462
Org. Lett., Vol. 6, No. 20, 2004